IBN
Închide

Lista articolelor cu rezumate în limba engleza

Print PDF
Afisarea articolelor: 1-3(3)
2020
1.

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

. Gastroenterology. 2020, nr. 2(159), 533-521. ISSN 0016-5085 ISSNe 1528-0012. (Cat. )
2.

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

. Gastroenterology. 2020, nr. 8(158), 2194-2180. ISSN 0016-5085 ISSNe 1528-0012. (Cat. )
3.

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

. Gastroenterology. 2020, nr. 3(158), 549-537. ISSN 0016-5085 ISSNe 1528-0012. (Cat. )
 
 

1-3 of 3